Alchemy Pay continues with its massive uptrend.
After hitting a low in mid-January, yes, the ALTSBTC pair hit their low in January 2023 as they have a slight delay compared to the ALTSUSDT, we've seen massive growth.
We have a new high today confirming/supporting the bullish case, total growth now reaching 190%+ after a little more than 30 days.
This is not bear-market type of action, this is recovery action, bounce from bottom, bull-market (higher highs and higher lows) comes next.
Namaste.
After hitting a low in mid-January, yes, the ALTSBTC pair hit their low in January 2023 as they have a slight delay compared to the ALTSUSDT, we've seen massive growth.
We have a new high today confirming/supporting the bullish case, total growth now reaching 190%+ after a little more than 30 days.
This is not bear-market type of action, this is recovery action, bounce from bottom, bull-market (higher highs and higher lows) comes next.
Namaste.
🚨 TOP FREE Trades
ETH +2050% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +580% · SOL +687%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6681
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +2050% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +580% · SOL +687%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6681
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 TOP FREE Trades
ETH +2050% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +580% · SOL +687%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6681
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
ETH +2050% · AAVE +1134%
XRP +749% · DOGS +868%
BTC +580% · SOL +687%
t.me/anandatrades/1350
🚨 FREE Analyses & New Results
t.me/masteranandatrades/6681
🚨 PREMIUM LIFETIME (Since 2017)
lamatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.